Sodium tetrametaphosphate (Na4P4O12) is a cyclic inorganic compound consisting of four phosphate units connected in a ring. It is a white, hygroscopic solid that is soluble in water. Sodium tetrametaphosphate is used in various industrial applications, including as a water softener, detergent builder, and food additive. The compound is synthesized through thermal dehydration of sodium dihydrogen phosphate (NaH2PO4) or by reacting sodium trimetaphosphate (Na3P3O9) with sodium chloride. The synthesis process involves careful control of temperature and time to form the desired cyclic structure. The compound exhibits various properties including its ability to form complexes with metal ions, which is utilized in its application as a water softener. It is also a strong chelating agent, capable of binding with calcium and magnesium ions, reducing their ability to react with other substances. Furthermore, sodium tetrametaphosphate can act as a corrosion inhibitor and a dispersant in different industrial applications. The compound is studied to understand its potential applications in various fields and to investigate its environmental impact. While sodium tetrametaphosphate is a versatile compound, it is important to assess its potential risks to the environment. Research explores ways to minimize its impact on aquatic ecosystems, where it can contribute to eutrophication. Studies also focus on developing sustainable and environmentally friendly alternatives to sodium tetrametaphosphate in various applications.'
sodium tetrametaphosphate: RN given refers to metaphosphoric acid, tetra-Na salt
ID Source | ID |
---|---|
PubMed CID | 25951 |
MeSH ID | M0077705 |
Synonym |
---|
metaphosphoric acid, tetrasodium salt |
tetrametaphosphoric acid, tetrasodium salt |
cyclophos |
metaphosphoric acid (h4p4o12), tetrasodium salt |
sodium cyclotetraphosphate (na4p4o12) |
tetrasodium cyclotetraphosphate |
sodium tetrametaphosphate (na4p4o12) |
hsdb 773 |
sodium cyclotetraphosphate (na4(p4o12)) |
sodium tetrametaphosphate |
tetrasodium tetrametaphosphate |
cyclofos |
einecs 236-482-6 |
tetrametaphosphoric acid (h4p4o12), tetrasodium salt |
13396-41-3 |
sodium metaphosphate (na4p4o12) |
unii-mlc36a7x39 |
mlc36a7x39 , |
tetrasodium tetrametaphosphate [hsdb] |
metaphosphoric acid (h4p4o12), sodium salt (1:4) |
DTXSID5074507 |
tetrasodium1,3,5,7-tetraoxido-2,4,6,8-tetraoxa-1lambda5,3lambda5,5lambda5,7lambda5-tetraphosphacyclooctane 1,3,5,7-tetraoxide |
UDEJEOLNSNYQSX-UHFFFAOYSA-J |
Q18212165 |
tetrasodium;2,4,6,8-tetraoxido-1,3,5,7,2lambda5,4lambda5,6lambda5,8lambda5-tetraoxatetraphosphocane 2,4,6,8-tetraoxide |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.95) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |